Abstract
Chronic methamphetamine (meth) abuse can lead to persisting cognitive deficits. Here, we utilized a long-access meth self-administration (SA) protocol to assess recognition memory and metabotropic glutamate receptor (mGluR) expression, and the possible reversal of cognitive impairments with the mGluR5 allosteric modulator, 3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl) benzamide (CDPPB). Male, Long-Evans rats self-administered i.v. meth (0.02 mg/infusion) on an FR1 schedule of reinforcement or received yoked-saline infusions. After seven daily 1-h sessions, rats were switched to 6-h daily sessions for 14 days, and then underwent drug abstinence. Rats were tested for object recognition memory at 1 week after meth SA at 90 min and 24 h retention intervals. In a separate experiment, rats underwent the same protocol, but received either vehicle or CDPPB (30 mg/kg) after familiarization. Rats were killed on day 8 or 14 post-SA and brain tissue was obtained. Meth intake escalated over the extended access period. Additionally, meth-experienced rats showed deficits in both short- and long-term recognition memory, demonstrated by a lack of novel object exploration. The deficit at 90 min was reversed by CDPPB treatment. On day 8, meth intake during SA negatively correlated with mGluR expression in the perirhinal and prefrontal cortex, and mGluR5 receptor expression was decreased 14 days after discontinuation of meth. This effect was specific to mGluR5 levels in the perirhinal cortex, as no differences were identified in the hippocampus or in mGluR2/3 receptors. These results from a clinically-relevant animal model of addiction suggest that mGluR5 receptor modulation may be a potential treatment of cognitive dysfunction in meth addiction.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Aggleton JP, Brown MW (2005). Contrasting hippocampal and perirhinal cortex function using immediate early gene imaging. Q J Exp Psychol B 58: 218–233.
Ahmed SH, Koob GF (1999). Long-lasting increase in the set point for cocaine self-administration after escalation in rats. Psychopharmacology 146: 303–312.
Ahmed SH, Walker JR, Koob GF (2000). Persistent increase in the motivation to take heroin in rats with a history of drug escalation. Neuropsychopharmacology 22: 413–421.
Alagarsamy S, Marino MJ, Rouse ST, Gereau RW, Heinemann SF, Conn PJ (1999). Activation of NMDA receptors reverses desensitization of mGluR5 in native and recombinant systems. Nat Neurosci 2: 234–240.
Awad H, Hubert GW, Smith Y, Levey AI, Conn PJ (2000). Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus. J Neurosci 20: 7871–7879.
Ayala JE, Chen Y, Banko JL, Sheffler DJ, Williams R, Telk AN et al (2009). mGluR5 positive allosteric modulators facilitate both hippocampal LTP and LTD and enhance spatial learning. Neuropsychopharmacology 34: 2057–2071.
Barker G, Warburton E (2008). NMDA receptor plasticity in the perirhinal and prefrontal cortices is crucial for the acquisition of long-term object-in-place associative memory. J Neurosci 28: 2837–2844.
Barker GR, Bashir ZI, Brown MW, Warburton EC (2006). A temporally distinct role for group I and group II metabotropic glutamate receptors in object recognition memory. Learning & Memory 13: 178–186.
Barker GRI, Bird F, Alexander V, Warburton EC (2007). Recognition memory for objects, place, and temporal order: a disconnection analysis of the role of the medial prefrontal cortex and perirhinal cortex. J Neurosci 27: 2948–2957.
Barker GRI, Warburton EC, Koder T, Dolman NP, More JCA, Aggleton JP et al (2006). The different effects on recognition memory of perirhinal kainate and NMDA glutamate receptor antagonism: implications for underlying plasticity mechanisms. J Neurosci 26: 3561–3566.
Belcher A, O’dell S, Marshall J (2005). Impaired object recognition memory following methamphetamine, but not p-chloroamphetamine- or d-amphetamine-induced neurotoxicity. Neuropsychopharmacology 30: 2026–2034.
Belcher AM, O’Dell SJ, Marshall JF (2006). A sensitizing regimen of methamphetamine causes impairments in a novelty perference task of object recognition. Behav Brain Res 170: 167–172.
Belcher AM, Feinstein EM, O’Dell SJ, Marshall JF (2008). Methamphetamine influences on recognition memory: comparison of escalating and single-day dosing regimens. Neuropsychopharmacology 33: 1453–1463.
Berlyne DE (1950). Novelty and curiosity as determinants of exploratory behavior. Br J Psychol 41: 68–80.
Bevins RA, Besheer J, Palmatier MI, Jensen HC, Pickett KS, Eurek S (2002). Novel-object place conditioning: behavioral and dopaminergic processes in expression of novelty reward. Behav Brain Res 129: 41–50.
Bisagno V, Ferguson D, Luine VN (2002). Short toxic methamphetamine schedule impairs object recognition task in male rats. Brain Res 940: 95–101.
Bortolato M, Frau R, Bini V, Luesu W, Loriga R, Collu M et al (2010). Methamphetamine neurotoxicity increases brain expression and alters behavioral functions of CB cannabinoid receptors. J Psychiatr Res (in press).
Briand LA, Gross JP, Robinson TE (2008). Impaired object recognition following prolonged withdrawal from extended-access cocaine self-administration. Neuroscience 155: 1–6.
Brown MW, Aggleton JP (2001). Recognition memory: what are the roles of the perirhinal cortex and hippocampus? Nat Rev Neurosci 2: 51–61.
Chang L, Alicata D, Ernst T, Volkow N (2007). Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction 102 (Suppl 1): 16–32.
Cho K, Kemp N, Noel J, Aggleton JP, Brown MW, Bashir ZI (2000). A new form of long-term depression in the perirhinal cortex. Nat Neurosci 3: 150–156.
Christoffersen GRJ, Simonyi A, Schachtman TR, Clausen B, Clement D, Bjerre VK et al (2008). MGlu5 antagonism impairs exploration and memory of spatial and non-spatial stimuli in rats. Behav Brain Res 191: 235–245.
Christopoulos A (2002). Allosteric binding sites on cell-surface receptors: novel targets for drug discovery. Nat Rev Drug Discov 1: 198–210.
Copani A, Romano C, Di Giorgi Gerevini V, Nicosia A, Casabona G, Storto M et al (2000). Reducing conditions differentially affect the functional and structural properties of group-I and -II metabotropic glutamate receptors. Brain Res 867: 165–172.
Darrah JM, Stefani MR, Moghaddam B (2008). Interaction of N-methyl-D-aspartate and group 5 metabotropic glutamate receptors on behavioral flexibility using a novel operant set-shift paradigm. Behav Pharmacol 19: 225–234.
Ennaceur A (2010). One-trial object recognition in rats and mice: methodological and theoretical issues. Behav Brain Res 215: 244–254.
Ennaceur A, Aggleton JP (1997). The effects of neurotoxic lesions of the perirhinal cortex combined to fornix transection on object recognition memory in the rat. Behav Brain Res 88: 181–193.
Ennaceur A, Delacour J (1988). A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data. Behav Brain Res 31: 47–59.
Ennaceur A, Neave N, Aggleton JP (1997). Spontaneous object recognition and object location memory in rats: the effects of lesions in the cingulate cortices, the medial prefrontal cortex, the cingulum bundle and the fornix. Exp Brain Res 113: 509–519.
Ernst T, Chang L (2008). Adaptation of brain glutamate plus glutamine during abstinence from chronic methamphetamine use. J Neuroimmune Pharmacol 3: 165–172.
Gass JT, Olive MF (2009). Positive allosteric modulation of mGluR5 receptors facilitates extinction of a cocaine contextual memory. Biol Psychiatry 65: 717–720.
Ghasemzadeh MB, Mueller C, Vasudevan P (2009). Behavioral sensitization to cocaine is associated with increased glutamate receptor trafficking to the postsynaptic density after extended withdrawal period. Neuroscience 159: 414–426.
Gonzalez R, Bechara A, Martin EM (2007). Executive functions among individuals with methamphetamine or alcohol as drugs of choice: preliminary observations. J Clin Exp Neuropsychol 29: 155–159.
Grimm JW, Lu L, Hayashi T, Hope BT, Su T-P, Shaham Y (2003). Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: Implications for incubation of cocaine craving. J Neurosci 23: 742–747.
Hoffman W, Moore M, Templin R, Mcfarland B, Hitzemann R, Mitchell S (2006). Neuropsychological function and delay discounting in methamphetamine-dependent individuals. Psychopharmacology 188: 162–170.
Kinney GG, O’Brien JA, Lemaire W, Burno M, Bickel DJ, Clements MK et al (2005). A novel selective positive allosteric modulator of metabotropic glutamate receptor subtype 5 has in vivo activity and antipsychotic-like effects in rat behavioral models. J Pharmacol Exp Ther 313: 199–206.
Kitamura O, Wee S, Specio SE, Koob GF, Pulvirenti L (2006). Escalation of methamphetamine self-administration in rats: a dose-effect function. Psychopharmacology 186: 48–53.
Krasnova IN, Justinova Z, Ladenheim B, Jayanthi S, McCoy MT, Barnes C et al (2010). Methamphetamine self-administration is associated with persistent biochemical alterations in striatal and cortical dopaminergic terminals in the rat. PLoS ONE 5: e8790.
Liu F, Grauer S, Kelley C, Navarra R, Graf R, Zhang G et al (2008). ADX47273 [S-(4-fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: a novel metabotropic glutamate receptor. J Pharmacol Exp Ther 327: 827–839.
Mandyam C, Wee S, Eisch A, Richardson H, Koob G (2007). Methamphetamine self-administration and voluntary exercise have opposing effects on medial prefrontal cortex gliogenesis. J Neurosci 27: 11442–11450.
Massey PV, Bashir ZI (2007). Long-term depression: multiple forms and implications for brain function. Trends Neurosci 30: 176–184.
Mitchell JB, Laiacona J (1998). The medial frontal cortex and temporal memory: tests using spontaneous exploratory behaviour in the rat. Behav Brain Res 97: 107–113.
Moussawi K, Pacchioni A, Moran M, Olive MF, Gass JT, Lavin A et al (2009). N-Acetylcysteine reverses cocaine-induced metaplasticity. Nat Neurosci 12: 182–189.
Mumby DG (2001). Perspectives on object-recognition memory following hippocampal damage: lessons from studies in rats. Behav Brain Res 127: 159–181.
Olive MF (2010). Cognitive effects of group I metabotropic glutamate receptor ligands in the context of drug addiction. Eur J Pharmacol 639: 47–58.
Paulus MP, Hozack N, Frank L, Brown GG, Schuckit MA (2003). Decision making by methamphetamine-dependent subjects is associated with error-rate-independent decrease in prefrontal and parietal activation. Biol Psychiatry 53: 65–74.
Pin J-P, Galvez T, Prézeau L (2003). Evolution, structure, and activation mechanism of family 3/C G-protein-coupled receptors. Pharmacol Ther 98: 325–354.
Rendell PG, Mazur M, Henry JD (2009). Prospective memory impairment in former users of methamphetamine. Psychopharmacology 203: 609–616.
Rogers J, Santis S, See R (2008). Extended methamphetamine self-administration enhances reinstatement of drug seeking and impairs novel object recognition in rats. Psychopharmacology 199: 615–624.
Schröder N, O’Dell SJ, Marshall JF (2003). Neurotoxic methamphetamine regimen severely impairs recognition memory in rats. Synapse 49: 89–96.
Salo R, Nordahl TE, Galloway GP, Moore CD, Waters C, Leamon MH (2009). Drug abstinence and cognitive control in methamphetamine-dependent individuals. J Subst Abuse Treat 37: 292–297.
Salo R, Nordahl TE, Natsuaki Y, Leamon MH, Galloway GP, Waters C et al (2007). Attentional control and brain metabolite levels in methamphetamine abusers. Biol Psychiatry 61: 1272–1280.
Salt TE, Binns KE (2000). Contributions of mGlu1 and mGlu5 receptors to interactions with N-methyl—aspartate receptor-mediated responses and nociceptive sensory responses of rat thalamic neurons. Neuroscience 100: 375–380.
Schwendt M, Rocha A, See R, Pacchioni A, Mcginty J, Kalivas P (2009). Extended methamphetamine self-administration in rats results in a selective reduction of dopamine transporter levels in the prefrontal cortex and dorsal striatum not accompanied by marked monoaminergic depletion. J Pharmacol Exp Ther 331: 555.
Scott JC, Woods SP, Matt GE, Meyer RA, Heaton RK, Atkinson JH et al (2007). Neurocognitive effects of methamphetamine: a critical review and meta-analysis. Neuropsychol Rev 17: 275–297.
Sekine Y, Ouchi Y, Sugihara G, Takei N, Yoshikawa E, Nakamura K et al (2008). Methamphetamine causes microglial activation in the brains of human abusers. J Neurosci 28: 5756–5761.
Simon SL, Dacey J, Glynn S, Rawson R, Ling W (2004). The effect of relapse on cognition in abstinent methamphetamine abusers. J Subst Abuse Treat 27: 59–66.
Stefani MR, Moghaddam B (2010). Activation of type 5 metabotropic glutamate receptors attenuates deficits in cognitive flexibility induced by NMDA receptor blockade. Eur J Pharmacol 639: 26–32.
Tran-Nguyen LTL, Fuchs RA, Coffey GP, Baker DA, O’Dell LE, Neisewander JL (1998). Time-dependent changes in cocaine-seeking behavior and extracellular dopamine levels in the amygdala during cocaine withdrawal. Neuropsychopharmacology 19: 48–59.
Uslaner JM, Parmentier-Batteur S, Flick RB, Surles NO, Lam JSH, McNaughton CH et al (2009). Dose-dependent effect of CDPPB, the mGluR5 positive allosteric modulator, on recognition memory is associated with GluR1 and CREB phosphorylation in the prefrontal cortex and hippocampus. Neuropharmacology 57: 531–538.
Volkow ND, Chang L, Wang G-J, Fowler JS, Franceschi D, Sedler M et al (2001a). Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci 21: 9414–9418.
Volkow ND, Chang L, Wang GJ, Fowler JS, Leonido-Yee M, Franceschi D et al (2001b). Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry 158: 377–382.
Wan H, Aggleton JP, Brown MW (1999). Different contributions of the hippocampus and perirhinal cortex to recognition memory. J Neurosci 19: 1142–1148.
Warburton EC, Brown MW (2010). Findings from animals concerning when interactions between perirhinal cortex, hippocampus and medial prefrontal cortex are necessary for recognition memory. Neuropsychologia 48: 2262–2272.
Winters BD, Bussey TJ (2005). Glutamate receptors in perirhinal cortex mediate encoding, retrieval, and consolidation of object recognition memory. J Neurosci 25: 4243–4251.
Winters BD, Forwood SE, Cowell RA, Saksida LM, Bussey TJ (2004). Double dissociation between the effects of peri-postrhinal cortex and hippocampal lesions on tests of object recognition and spatial memory: Heterogeneity of function within the temporal lobe. J Neurosci 24: 5901–5908.
Zhu XO, Brown MW, McCabe BJ, Aggleton JP (1995). Effects of the novelty or familiarity of visual stimuli on the expression of the immediate early gene c-fos in rat brain. Neuroscience 69: 821–829.
Acknowledgements
This research was supported by NIH grants P20DA022658 (RES), F32DA029344(CMR), T32DA007288(CMR), R01DA024355 (MFO), and C06 RR015455. The authors thank Shannon Ghee, Clifford Chang, Lauren Ramsey, and Stacey Sigmon for technical assistance.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Neuropsychopharmacology website
Supplementary information
Rights and permissions
About this article
Cite this article
Reichel, C., Schwendt, M., McGinty, J. et al. Loss of Object Recognition Memory Produced by Extended Access to Methamphetamine Self-Administration is Reversed by Positive Allosteric Modulation of Metabotropic Glutamate Receptor 5. Neuropsychopharmacol 36, 782–792 (2011). https://doi.org/10.1038/npp.2010.212
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/npp.2010.212
Keywords
This article is cited by
-
Sex differences in behavior, cognitive, and physiological recovery following methamphetamine administration
Psychopharmacology (2024)
-
Cellular messenger molecules mediating addictive drug-induced cognitive impairment: cannabinoids, ketamine, methamphetamine, and cocaine
Future Journal of Pharmaceutical Sciences (2022)
-
The effect of chronic oxytocin treatment during abstinence from methamphetamine self-administration on incubation of craving, reinstatement, and anxiety
Neuropsychopharmacology (2020)
-
Neurochemical and behavioral comparisons of contingent and non-contingent methamphetamine exposure following binge or yoked long-access self-administration paradigms
Psychopharmacology (2020)
-
The cognitive cost of reducing relapse to cocaine-seeking with mGlu5 allosteric modulators
Psychopharmacology (2020)
